Gerber Kawasaki Wealth & Investment Management »

Crispr Therapeutics shares owned by Gerber Kawasaki Wealth & Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gerber Kawasaki Wealth & Investment Management from 13F filings

Historical chart of Gerber Kawasaki Wealth & Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Gerber Kawasaki Wealth & Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Gerber Kawasaki Wealth & Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $973k 21k 47.57
2021-09-30 $103k 927 111.11

More positions owned by Gerber Kawasaki Wealth & Investment Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr Series Trust State Street Spd (SPYG)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Us Aggbd Et (AGG)
Tesla Motors (TSLA)
Apple (AAPL)
Select Sector Spdr Tr State Street Tec (XLK)
Alphabet Cap Stk Cl C (GOOG)
Select Sector Spdr Tr State Street Fin (XLF)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Hea (XLV)
Spdr Series Trust State Street Spd (LGLV)
Microsoft Corporation (MSFT)

View all positions for Gerber Kawasaki Wealth & Investment Management

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Susquehanna International
Two Sigma Investments

View all funds holding Crispr Therapeutics